Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: Comparison with protein A and protein G

Journal of Immunological Methods

Volumn 271, Issue 1-2, 2002, Pages 77-88

  Verdoliva, Antonio ^a   Pannone, Filomena ^a   Rossi, Maria ^a   Catello, Sergio ^a   Manfredi, Vincenzo ^a  

^a TECNOGEN SCpA   (Italy)

Author keywords

Affinity purification; Inverso peptide; Polyclonal antibody

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIGAND; PEPTIDE; POLYCLONAL ANTIBODY; PROTEIN A; PROTEIN G; PROTEINASE;

ARTICLE; AUTOCLAVE; BINDING AFFINITY; CHROMATOGRAPHY; CONTROLLED STUDY; ELUTION; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STABILITY; PURIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOMIMETIC MATERIALS; BLOTTING, WESTERN; CARRIER PROTEINS; CATTLE; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GOATS; HORSES; HUMANS; IMMUNOGLOBULIN G; MICE; NERVE TISSUE PROTEINS; PROTEIN CONFORMATION; RABBITS; STAPHYLOCOCCAL PROTEIN A;

BOVINAE; CAPRA HIRCUS; EQUUS CABALLUS; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

EID: 0037146780     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00341-1     Document Type: Article

References (38)

1. Achiron A., Gabbay U., Gilad R., Hassain-Baer S., Barak Y.et al. Intravenous immunoglobulin treatment in multiple sclerosis: effect on relapses. Neurology. 52:1999;589.
2. Achiron A., Mor F., Margalit R., Cohen I.R., Lider O., Miron S. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins. J. Autoimmun. 15:2000;323.
3. Akerstrom B., Brodin T., Reis K., Bjorck L. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J. Immunol. 135:1985;2589.
4. Atkins J.T., Karimi F., Morris E.H., Mc David G., Shim S. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost. Pediatr. Infect. Dis. J. 19:2000;138.
5. Balthasar J., Fung H.L. High-affinity rabbit antibodies directed against methotrexate: production, purification, characterization, and pharmacokinetics in the rat. J. Pharm. Sci. 84:1995;2.
6. Brennan D.C. Polyclonal antibodies in immunosuppression. Transplant. Proc. 33:2001;1002.
7. Calabozo B., Duffort O., Carpizo J.A., Barber D., Polo F. Monoclonal antibodies against the major allergen of Plantago lanceolata pollen, Pla 1 1: affinity chromatography purification of the allergen and development of an ELISA method for Pla 1 1 measurement. Allergy. 56:2001;429.
8. Cheung H.Y., Chan K.M., Ng T.B., Cheng C.H. Production of a polyclonal antibody against recombinant goldfish prolactin and demonstration of its usefulness in a non-competitive antigen-capture ELISA. Comp. Biochem. Physiol., B, Biochem. Mol. Biol. 131:2002;37.
9. Chou S.F., Chen C.Y. Monoclonal and polyclonal antibodies against human ferritin, a nonspecific tumormarker. Hybridoma. 20:2001;59.
10. Clark M., Bindon C., Dyer M., Friend P., Hale G., Cobbold S., Calne R., Waldmann H. The improved lytic function and in vivo efficacy of monovalent monoclonal CD3antibodies. Eur. J. Immunol. 19:1989;381.
11. Dalakas M.C., Illn I., Dambrosia J.M., Soueidan S.A., Stein D.P., Otero C.et al. A controlled trial of high-dose intravenous immunoglobulin infusions as treatment of dermatomyositis. New Engl. J. Med. 349:1993;1123.
12. Fassina G. Oriented immobilization of peptide ligands on solid supports. J. Chromatogr. 591:1992;99.
13. Fassina G., Verdoliva A., Odierna M.R., Ruvo M., Cassani G. Protein A Mimetic ligand for affinity purification of antibodies. J. Mol. Recognit. 9:1996;564.
14. Fassina G., Verdoliva A., Palombo G., Ruvo M., Cassani G. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification. J. Mol. Recognit. 11:1998;128.
15. Fassina G., Ruvo M., Palombo G., Verdoliva A., Marino M. Novel ligand for the affinity-chromatographic purification of antibodies. J. Biochem. Biophys. Methods. 49:2001;481.
16. Fuglistaller P. Comparison of immunoglobulin binding capacities and ligand leakage using eight different protein A affinity chromatography matrices. J. Immunol. Methods. 124:1989;171.
17. Gagnon P., 1996. Purification tools for monoclonal antibodies. Validated Biosystem, p. 155.
18. Gallacher G. Polyclonal catalytic antibodies. Biochem. Soc. Trans. 21:1993;1087.
19. Gathumbi J.K., Usleber E., Martlbauer E. Production of ultrasensitive antibodies against aflatoxin B1. Lett. Appl. Microbiol. 32:2001;349.
20. Gelfand M.D. Antibody-directed therapy: past, present and future. J. Allergy Clin. Immunol. 108:2001;S111.
21. Godfrey M.A., Kwasowski P., Clift R., Marks V. Assessment of the suitability of commercially available SpA affinity solid phases for the purification of murine monoclonal antibodies at process scale. J. Immunol. Methods. 160:1993;97.
22. Hale G., Drumm A., Harrison P., Phillips J. Repeated cleaning of protein A affinity column with sodium hydroxide. J. Immunol. Methods. 171:1994;15.
23. Hann A.F., Bolton C.F., Zochodne D.et al. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind placebo-controlled cross-over study. Brain. 119:1996;1067.
24. Hong H.A., Rooijakkers E.J., Ke N.T., Groen J., Osterhaus A.D. Methods for the purification of equine rabies immunoglobulin: effects on yield and biological activity. Biologicals. 22:1994;1.
25. Josic D., Hofmann W., Habermann R., Schulzke J.D., Reutter W. Isolation of immunoglobulins and their use in immunoaffinity HPLC. J. Clin. Chem. Clin. Biochem. 26:1988;559.
26. Lories R.J., Maertens J.A., Ceuppens J.L., Peetermans W.E. The use of intravenous immunoglobulins in the prevention and treatment of infectious diseases. Acta Clin. Belg. 55:2000;163.
27. Newburger J.M., Takahashi M., Burns J.C., Belser A.S., Chung K.J., Duffy C.E.et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315:1986;341.
28. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst. Rev. (2):2001;CD000361.
29. Palombo G., Rossi M., Cassani G., Fassina G. Affinity purification of mouse monoclonal IgE using a protein A mimetic ligand. J. Mol. Recognit. 11:1998;247.
30. Palombo G., De Falco S., Tortora M., Cassani G., Fassina G. A synthetic ligand for IgA affinity purification. J. Mol. Recognit. 11:1998;243.
31. Palombo G., Verdoliva A., Fassina G. Affinity purification of IgM using a novel synthetic ligand. J. Chromatogr., B Biomed. Sci. Appl. 715:1998;137.
32. Shin K., Hayasawa H., Lonnerdal B. Purification and quantification of lactoperoxidase in human milk with use of immunoadsorbents with antibodies against recombinant human lactoperoxidase. Am. J. Clin. Nutr. 73:2001;984.
33. Stanker L.H., Vanderlaan M., Juarez-Salinas H. One-step purification of mouse monoclonal antibodies from ascites fluid byhydroxylapatite chromatography. J. Immunol. Methods. 76:1985;157.
34. Subramanian A. Immunoaffinity chromatography. Mol. Biotechnol. 20:2002;41.
35. Thomas T.M., Shave E.E., Bate I.M., Gee S.C., Franklin S., Rylatt D.B. Preparative electrophoresis: a general method for the purification of polyclonal antibodies. J. Chromatogr., A. 944:2002;161.
36. Verdoliva A., Basile G., Fassina G. Affinity purification of immunoglobulins from chicken egg yolk using a new synthetic ligand. J. Chromatogr., B. 749:2000;233.
37. Werdan K. Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr. Opin. Crit. Care. 7:2001;354.
38. Yan Z., Huang J. Chromatographic behavior of mouse serum immunoglobulin G in protein G perfusion affinity chromatography. J. Chromatogr., B, Biomed. Sci. Appl. 738:2000;149.